Timothy Schmid, Executive Vice President and Worldwide Chair of Medtech at Johnson & Johnson (JNJ), executed a significant sale of company shares on September 4, 2026. Schmid sold 22,527 shares at an average price of $274.74 each, realizing approximately $6.19 million from the transaction.
This sale follows other recent insider transactions at Johnson & Johnson. Earlier in September, Schmid had also sold 11,070 shares for roughly $3.04 million. Additionally, other executives, including Joaquin Duato and Elizabeth Forminard, have made notable share sales in August.
Insider sales can be attributed to various personal financial decisions, such as portfolio diversification or tax planning, and do not necessarily indicate a shift in the insider's or the company's fundamental outlook.